The genomic testing platform developer has now raised some $140m, eight years after being co-founded in EPFL's Innovation Park by researchers from EMBL, Stanford and Geneva University.

Switzerland-based genomics technology provider Sophia Genetics has raised $77m in funding from investors led by investment firm Generation Investment Management.
Private equity firm Idinvest Partners, venture capital firm Balderton Capital and Alychlo, the investment vehicle for pharmaceutical entrepreneur Marc Coucke, also contributed to the round.
Founded in 2011, Sophia has developed a clinical genomics analytics platform intended to help healthcare professionals diagnose and treat patients for cancer and hereditary disorders by more thoroughly analysing genomic and radiomic data.…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?